Viewing Study NCT01497093


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2026-02-01 @ 5:46 AM
Study NCT ID: NCT01497093
Status: COMPLETED
Last Update Posted: 2020-04-07
First Post: 2011-12-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Sponsor:
Organization: